Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel Arm, Placebo-Controlled, Double-Blind, Multiple-Dose Study of the Safety and Efficacy of RN624 in Adults With Moderate-to-Severe Pain Due to Osteoarthritis of the Knee

NCT00394563 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00394563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00394563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel Arm, Placebo-Controlled, Double-Blind, Multiple-Dose Study of the Safety and Efficacy of RN624 in Adults With Moderate-to-Severe Pain Due to Osteoarthritis of the Knee
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2006
Completion date
October 31, 2007
Enrollment
450 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis